Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission-confounded by the gut microbiome?

Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission-confounded by the gut microbiome?

Aliment Pharmacol Ther. 2019 Apr;49(8):1086-1087

Authors: Leong RWL, Kaakoush NO, Yau YY, Wasinger VC

PMID: 30920041 [PubMed – in process]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/30920041?dopt=Abstract